1 |
What is the primary function of AI in the medical imaging industry?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
What does AI literacy refer to according to the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
How is the STEM-PD product manufactured?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|